je.st
news
Home
› RetroSense Therapeutics' Lead Gene Therapy Candidate Gets FDA Clearance To Proceed To First-In-Human Clinical Trials
RetroSense Therapeutics' Lead Gene Therapy Candidate Gets FDA Clearance To Proceed To First-In-Human Clinical Trials
2015-09-02 07:40:59| drugdiscoveryonline News Articles
RetroSense Therapeutics LLC, a privately-held biopharmaceutical company, recently announced the Company’s Investigational New Drug (IND) application for RST-001 received clearance from the United States Food and Drug Administration (FDA)
Tags: lead
clinical
therapy
candidate
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||